arrow
M

Monica Schiavini

luigi sacco hospital
H指数:14
被引数:818

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort

新型β-内酰胺类药物在免疫脆弱患者中的实际应用:来自意大利回顾性队列研究的见解

2026-08-240
OAAI
Time to positivity in bacterial and Candida spp. catheter-related bloodstream infections: a single-centre retrospective analysis

细菌和<em>Candida</em> spp.导管相关性血流感染中阳转时间:一项单中心回顾性分析

2026-08-070
OAAI
Risk factors associated with mortality in patients with catheter-related and catheter-associated bloodstream infections: a retrospective observational study focused on CVADs and midlines

与中心静脉导管(CVADs)和中等长度导管相关的血流感染患者的死亡相关风险因素:一项关注CVADs和中等长度导管的回顾性观察性研究

2025-12-170
OAAI
The CONSIDER study: Assessing the risk of catheter-associated bloodstream infections beyond the intensive care setting

CONSIDER研究:评估重症监护室以外环境中导管相关血流感染的风险

2025-06-060
PRE
Effectiveness of Vascular Catheter Removal Versus Retention in Non-ICU Patients with CRBSI or CABSI in Retrospective, Single-Center Study

非ICU患者中血管导管移除与保留在CRBSI或CABSI治疗中的效果比较:一项回顾性单中心研究

2025-05-070
OA
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease
2024-03-202
OAAI
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

格列卡普韦/皮布伦他韦治疗慢性丙型肝炎患者的有效性和安全性: 一项上市后观察性研究的意大利队列结果

2021-05-014
PREAI
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort
2020-02-0315
PREAI
Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis
2019-10-2154
OAAI
Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
2019-04-011
PREAI
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy
2019-04-011
PREAI
Treatment of genotype 3 HCV infection in the large real-life Navigatore Lombardia multicentre cohort: Results from three different regimens
2019-04-011
PREAI
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

glecaprevir/pibrentasvir在723例慢性丙型肝炎患者中的真实世界有效性和安全性

2019-03-01103
PREAI
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients
2019-02-010
PREAI
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
2019-02-010
PREAI